Teleflex says it's having trouble developing the medical device coating technology it acquired along with Semprus BioSciences for up to $80 million.
Teleflex (NYSE:TFX) is having trouble developing the anti-microbial coating technology it acquired along with Semprus BioSciences for up to $80 million in 2012, according to a regulatory filing.
Teleflex Medical's recall of the ISIS HVT tracheal tube is labelled by the FDA as Class I, denoting the risk of serious injury or death.
The voluntary recall by Teleflex Medical (NYSE:TFX) of its Isis HVT tracheal tube was given Class I status by the FDA, denoting the risk of serious injury or death.
Teleflex said it issued the recall because of the potential for the tracheal tube to kink and deprive patients of ventilation, possibly leading to hypoxic injury or anoxia.
Teleflex cuts its constant-currency sales outlook for 2013, sending shares down slightly on Wall Street.
Teleflex (NYSE: TFX) shares slipped a bit this morning after the medtech company said it's lowering its constant-currency sales outlook for this year.
Teleflex ties a ribbon around its $263 million acquisition of inside-the-bone access devices maker Vidacare Corp.
Pennsylvania technology giant Teleflex (NYSE:TFX) put the finishing touches on a $263 million acquisition of Vidacare Corp., a company that makes inside-the-bone access devices.
Group purchasing organization Novation awards a supply deal to Teleflex for its Arrow intra-aortic balloon catheters and pumps.
Group purchasing organization Novation inked a new contract with medical device company Teleflex (NYSE:TFX).
The deal calls for the Limerick, Pa.-based medical device company to provide its complete line of Arrow intra-aortic balloon catheters and pumps. The agreement is slated to begin Jan. 1, 2014.
Teleflex plans to consolidate its operations in North Carolina, adding 75 jobs in the process.
Teleflex (NYSE:TFX) plans to add 75 jobs to its North Carolina operations after it finished building a new facility.
Teleflex, which employs 442 workers in 2 offices in Durham, is planning to consolidate those offices into a single facility in Morrisville, N.C.
Orthofix chairman Jim Gero steps down and is replaced by private equity player Randy Thurman.
Orthofix (NSDQ:OFIX) chairman Jim Gero stepped down, effective immediately, to be replaced by Randy Thurman.
Gero, a member of the orthopedic medical device company's board since 1998, was named chairman in 2005. He'll continue as a consultant to the board until 2015, according to a press release.